ADHD, an anxiety disorder or depression can change treatment in autism considerably. What matters is which symptoms interact and what help actually relieves everyday life. A current British report therefore calls for care that looks at mental health and neurological development together.
An autistic person can have ADHD, depression or a physical illness at the same time. Experts speak of co-occurring conditions or comorbidities. An additional diagnosis does not yet say, however, which problem is causing the most strain at the moment and which treatment step should take priority.
The British report on mental health, ADHD and autism, published in October 2026, recommends interdisciplinary teams and better-connected assessment and support. It concerns care in England and is not a new therapy study. Its demand nevertheless makes a central question visible. How can it be prevented that, with several diagnoses, each service sees only part of the person?
New symptoms deserve a separate assessment
If an autistic person suddenly seems more irritable, sleeps worse or behaves differently, this should be a reason for renewed assessment. Pain, physical illnesses and side effects of medications can change behaviour.
A treatment proposal by a team at the American Lurie Center for Autism, published in BMC Medicine in 2025, also points to this. The experts name, among other things, dental problems and constipation as possible causes of symptoms. Their article combines research literature and clinical experience. It is an expert consensus, not a controlled test of a new treatment concept.
A short observation list can help in preparing an appointment. Since when has the change existed? What was different before? Were there new medications, pain or changed everyday conditions? Such information gives the medical assessment a concrete starting point.
Basics are explained in our knowledge article on co-occurring conditions in autism.
Psychotherapy must be understandable and accessible
For an additional mental health condition, the British guideline body NICE recommends that adults be treated according to the recommendations for the respective condition. At the same time, delivery should be adapted to the needs of autistic people.
This includes clear wording, a comprehensible sequence and written or visual aids. Abstract explanations can be supplemented with concrete everyday situations. Breaks and agreed structures can make taking part easier. Relatives can be involved with the consent of the person concerned.
For children and young people with autism and anxiety, NICE recommends considering adapted cognitive behavioural therapy if the language and cognitive prerequisites for this approach are present. Among other things, stressful thoughts and patterns of behaviour are worked on. The recommendation cannot be transferred unchanged to every child. Children with higher support needs also need access to treatment that suits their means of communication.
Further information is provided by our overview of psychotherapy in autism.
ADHD requires carefully supervised treatment
When ADHD is also present, autism does not rule out drug treatment in principle. NICE in principle provides the same choices as for ADHD without autism. The concrete decision depends on the individual situation, however.
For autism or additional mental or certain physical conditions, the guideline recommends slower dose adjustment and more frequent monitoring. Effectiveness, strain in everyday life and unwanted effects are to be recorded over time. A good effect on attention, for example, does not yet answer the question of whether sleep and wellbeing also remain stable.
The recommendations come from the United Kingdom. Which treatment is possible in Germany has to be decided by the treating professional, taking age, authorisation and individual medical history into account.
With several medications, the whole course matters
The Lurie Center treatment proposal stresses regular monitoring of benefits and side effects. People who find it hard to communicate symptoms in words in particular can show unwanted effects through changes in their behaviour.
For a treatment conversation, a complete overview of the medications taken is therefore helpful. This includes the reason for prescribing, changes over time and symptoms observed. The treating professionals should clarify together what effect is aimed for and who carries out the monitoring. Changes to medication belong under medical supervision.
Our knowledge article on medication in autism places the basic options in context.
Research still leaves questions open
How well adapted mental health services work has not yet been sufficiently clarified for all procedures and groups of people. A systematic review by Sofia Loizou and her team, published in 2024, evaluated 30 papers on the care of autistic adults.
Many adaptations studied seemed practicable and were accepted. For clear statements on effectiveness, however, the evidence overall was not sufficient. The studies differed markedly in design and quality. It follows neither that psychotherapy would be ineffective in general, nor that a particular combination reliably helps with several diagnoses. What remains decisive is a professionally justified approach and checking the individual benefit.
What should be in a coordinated treatment plan
A shared list of questions for practice can be derived from the recommendations. Which symptoms take priority at present? What goal is important to the person concerned? Who coordinates the treatment? When will it be checked whether the measures chosen are helping?
For ADHD, NICE recommends a comprehensive, jointly agreed treatment plan that also takes other diagnoses and needs at school, work and in everyday life into account. For autistic people, communication, sensitivity to stimuli and the accessibility of appointments should also feed into the planning.
One goal can be to take part in a desired activity again or to manage a stressful everyday step better. What change counts should be set together with the person concerned. The British report accordingly calls for care also to be measured by participation and quality of life.
With several diagnoses, every measure needs a comprehensible purpose. A coordinated treatment plan records what is being treated, who is responsible and how an improvement can be recognised.
Sources
- Independent review into mental health conditions, ADHD and autism.
British independent report, published on 9 October 2026,
updated on 21 October 2026. - NICE CG142 on the diagnosis and care of adults with autism.
Published on 27 June 2012, last updated on 14 June 2021.
In particular sections 1.3 and 1.6. - NICE CG170 on the support and treatment of children and young people with autism.
Published on 28 August 2013, last updated on 14 June 2021.
In particular sections 1.1 and 1.7. - NICE NG87 on the diagnosis and treatment of ADHD.
Published on 14 March 2018, last updated on 13 September 2019.
In particular recommendations 1.5.2, 1.7.18 and 1.7.28. - Manter and team, Pharmacological treatment in autism.
BMC Medicine, published on 7 January 2025.
Expert-based treatment proposal.
DOI 10.1186/s12916-024-03814-0. - Loizou and team, Approaches to improving mental healthcare for autistic people.
BJPsych Open, published online on 1 August 2024.
Systematic review.
Found a mistake?
If something is factually wrong, out of date or unclear, let us know. You do not have to give any personal details.



